Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS · Delayed Price · Currency is USD
0.0016
+0.0014 (700.00%)
At close: Apr 7, 2026

Hemagen Diagnostics Revenue

In the fiscal year ending September 30, 2012, Hemagen Diagnostics had annual revenue of $4.04M, down -21.38%. Hemagen Diagnostics had revenue of $875.91K in the quarter ending September 30, 2012, a decrease of -23.58%.

Revenue
4.04M
Revenue Growth
-21.38%
P/S Ratio
0.01
Revenue / Employee
269.47K
Employees
15
Market Cap
24.80K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 20124.04M-1.10M-21.38%
Sep 30, 20115.14M-78.94K-1.51%
Sep 30, 20105.22M-198.76K-3.67%
Sep 30, 20095.42M-955.87K-14.99%
Sep 30, 20086.37M1.89M42.07%
Sep 30, 2007 Pro Pro Pro
Sep 30, 2006 Pro Pro Pro
Sep 30, 2005 Pro Pro Pro
Sep 30, 2004 Pro Pro Pro
Sep 30, 2003 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ObsEva19.64M
Statera Biopharma3.69M
Trevena546.00K
America Great Health391.74K
Health Sciences Group69.31K
NanoLogix1.27K
Revenue Rankings